Skip to main content
Premium Trial:

Request an Annual Quote

Arcis Biotechnology, Teleflex Sign License Agreement

NEW YORK (GenomeWeb) – Arcis Biotechnology announced yesterday that it has signed a technology access agreement with Teleflex.

As part of the agreement, Teleflex will use Arcis' nucleic acid sample preparation chemistry to develop a rapid diagnostic assay using RNA detection. Arcis' two-step nucleic acid extraction and preservation technology enables earlier, more accurate diagnostic testing from a variety of sample types, the company said.

This partnership comes after Arcis' announcement earlier this month that it had raised £1.3 million ($1.7 million) in an investment round. The firm now plans to invest further in research and development, product development, and international business expansion.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.